Humana (HUM) Tops Q2 EPS by 41c, Lifts FY EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
Humana (HUM) PT Raised to $230 at Cantor Fitzgerald Following 2Q Release
August 2, 2017 1:17 PM EDTCantor Fitzgerald raised its price target on Humana (NYSE: HUM) to $230.00 (from $200.00) while maintaining a Neutral rating following the company's 2Q earnings report. Non-GAAP EPS was $3.49 vs. recast 2Q16 nonGAAP EPS of $3.29. Medicare revenue grew 3.3% y/y compared to 1.2% in 1Q17.
The company... More
